Brief Report: Self-Reported Medication Use in Individuals Diagnosed with Autism Spectrum Disorder in Adulthood: A U.S. Clinic Sample from 2012 to 2022
Journal of Autism and Developmental Disorders · 2024
DOI: 10.1007/s10803-024-06397-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Autism and Developmental Disorders, 2024. Verfasst von A K Izuno-Garcia und 3 weiteren Autor:innen. Beteiligte Einrichtung: Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center, Houston,…. Hauptthemen laut MEDLINE: Autism Spectrum Disorder, Self Report, Psychotropic Drugs. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: As the understanding of autism spectrum disorder (ASD) across the lifespan has increased, so has the number of individuals being identified with ASD for the first time in adulthood. Understanding co-occurring psychiatric conditions in this subset of the ASD population is a growing focus of research; however, little is known about the rate at which psychiatric medications are prescribed to adults with a first-time diagnosis of ASD. The purpose of this study was to examine self-reported medication use in persons diagnosed with ASD in adulthood in a clinic sample (2012-2022) in the United States. METHODS: The present study was a retrospective record review. Participants (n = 281) were drawn from an outpatient clinic specializing in the diagnosis of ASD in adults. Participants self-reported previous and current psychiatric medication prescription using a medication checklist. RESULTS: Approximately 50% of participants self-reported being prescribed at least one psychiatric medication at the time of their initial evaluation appointment. The most commonly prescribed psychiatric medications were antidepressants (23.8%), followed by stimulants (16.7%). CONCLUSION: Similar to individuals diagnosed with ASD in childhood, those identified with ASD for the first time in adulthood are prescribed psychiatric medication at a much higher rate than their same-age non-autistic peers. These results can inform future research and practice for improving outcomes for autistic adults, particularly those who were undiagnosed for much of their lives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA. amy.k.garcia@uth.tmc.edu.
- Louis A. Faillace, MD, Department of Psychiatry and Behavioral Sciences, McGovern Medical School, University of Texas Health Science Center, Houston, TX, USA.
Zitieren
APA
Izuno-Garcia, A. K., Vanderburg, J. L., Pagán, A. F., & Loveland, K. A. (2024). Brief Report: Self-Reported Medication Use in Individuals Diagnosed with Autism Spectrum Disorder in Adulthood: A U.S. Clinic Sample from 2012 to 2022. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-024-06397-0
Vancouver
Izuno-Garcia AK, Vanderburg JL, Pagán AF, Loveland KA. Brief Report: Self-Reported Medication Use in Individuals Diagnosed with Autism Spectrum Disorder in Adulthood: A U.S. Clinic Sample from 2012 to 2022. Journal of Autism and Developmental Disorders. 2024. doi:10.1007/s10803-024-06397-0
BibTeX
@article{IzunoGarcia2024,
author = {Izuno-Garcia, A K and Vanderburg, J L and Pagán, A F and Loveland, K A},
title = {Brief Report: Self-Reported Medication Use in Individuals Diagnosed with Autism Spectrum Disorder in Adulthood: A U.S. Clinic Sample from 2012 to 2022},
journal = {Journal of Autism and Developmental Disorders},
year = {2024},
doi = {10.1007/s10803-024-06397-0}
}
EUVIMED